Difference between revisions of "WSI21-216-Case-1"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 68: Line 68:
 
|subject=Z0FBQUFBQmhxVFFVbi1lTDgxaDVrTW54a3lhQUNJZGZDS2VQbGpNbGlkb1RLQUE5V3k1cFpFSEhNUEJ1SV9sY0t1eXFUSG43NEJVVzJqbzZYV0pkQjR5SVBURG4yWFhMd3c9PQ
 
|subject=Z0FBQUFBQmhxVFFVbi1lTDgxaDVrTW54a3lhQUNJZGZDS2VQbGpNbGlkb1RLQUE5V3k1cFpFSEhNUEJ1SV9sY0t1eXFUSG43NEJVVzJqbzZYV0pkQjR5SVBURG4yWFhMd3c9PQ
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Vn048
 +
|authoredOn=December 02, 2021 08:55:33 PM
 
}}
 
}}

Latest revision as of 14:14, December 9, 2024

WSI21-216-Case-1
65 yo woman with leukocytosis (WBC 20.42; HGB 13.1; HCT: 39.8%; MCV: 85.4; PLT: 348) and occasional circulating blasts.
Post-polycythemia vera myelofibrosis
December 8, 2021 12:00:00 AM